METHOD FOR INSERTION OF 1,2-DOUBLE BOND INTO 3-OXO-4-AZASTEROID COMPOUNDS Russian patent published in 2008 - IPC C07J73/00 

Abstract RU 2321592 C2

FIELD: organic chemistry, chemical technology.

SUBSTANCE: invention describes an improved method for synthesis of 17β-substituted 4-azaandrost-1-en-3-one of the general formula (I): wherein R means -OH, (C1-C4)-alkyl, (C1-C4)-alkenyl, phenyl, benzyl and others, or their pharmaceutically acceptable salts. Method involves insertion protective groups into 3-keto-4-aza (lactam) form of compound of the general formula (II): wherein R has indicated values to form compound of the general formula (III): wherein R3 means trialkylsilyl, or in common with R4 residue -C(O)-C(O)- or -C(O)-Y-C(O)- wherein R4 means tert.-butyloxycarbonyl preferably; Y means -(CH2)n wherein n = 1-4, or ortho-phenylene. Then a synthesized compound is converted in the presence of a dehydrogenation catalyst of in the presence of benzoquinone, allylmethylcarbonate, allylethylcarbonate and/or allylpropylcarbonate, and ▵1-double bond is introduced in 1,2-position followed by removal of protective groups and, if necessary, (when R means -OH) conversion to salts. Method provides the high yield and purity degree of synthesized compounds.

EFFECT: improved method of synthesis.

21 cl, 9 ex

Similar patents RU2321592C2

Title Year Author Number
METHOD OF TREATMENT OF PATIENTS WITH PROSTATE BENIGNITY HYPERPLASIA, PHARMACEUTICAL PREPARATION CONTAINING INHIBITOR OF 5-ALPHA-REDUCTASE 1992
  • Glenn Dzh.Gomlej
  • Ehlizabet Stoner
RU2125879C1
FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION 1993
  • Akille Pantseri
  • Marchella Nesi
  • Ehnriko Di Salle
RU2125061C1
INHIBITORS OF TESTOSTERONE 5α-REDUCTASE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TESTOSTERONE 5α-REDUCTASE ACTIVITY 1993
  • Fernand Labri
  • Iv Meran
  • Shankar M.Singkh
RU2141967C1
ANTIANDROGENIC COMPOUNDS, PRECURSOR OF ANTIANDROGENIC COMPOUND, PHARMACEUTICAL COMPOSITIONS 1993
  • Fernand Labri
  • Iv Merand
  • Shankar M.Singkh
RU2141966C1
ANDROSTEN(ANE) (ONE) DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF, METHODS OF PREPARATION THEREOF, AND METHOD OF MEDICAL TREATMENT 1994
  • Behchelor Kennet Uil'Jam
  • Fraj Stiven Vernon
RU2144037C1
3-CYANOANDROSTA-3,5-DIENE-17BETA-CARBOXYLIC ACID AS INTERMEDIATE PRODUCT, AND METHOD OF PREPARING COMPOUNDS 1993
  • Koiti Kodzima
  • Khitosi Kurata
  • Koki Isibasi
  • Takakazu Khamada
  • Khirojossi Khorikosi
RU2114861C1
POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR 2021
  • Zhang, Hancheng
  • Cheng, Xin
  • Jia, Wei
  • Cai, Congcong
RU2826488C1
17$$$-SUBSTITUTED 3-CARBOXYSTEROIDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION 1992
  • Akille Pantseri[It]
  • Marchella Nesi[It]
  • Ehnriko Di Salle[It]
RU2104283C1
DOUBLE ANTITHROMBOTIC INHIBITORS CONTAINING BIOTIN RESIDUE 2005
  • De Kort Martin
  • Van Bukkel Konstant Adrian Anton
RU2403259C2
DERIVATIVES OF PYRROLO[2,3-D]PYRIMIDINES, PHARMACEUTICAL COMPOSITION, PYRROLO[2,3-D]PYRIMIDINES, DERIVATIVES OF PYRROLE 1993
  • Jukhping L.Chen
RU2124015C1

RU 2 321 592 C2

Authors

Sherer Norbert

Veber Beat

Mjuller Beat V.

Dates

2008-04-10Published

2003-07-02Filed